MapLight Therapeutics is a clinical-stage biopharma focused on CNS disorders and has filed for a $100M U.S. IPO to fund its ...
CNS stimulants and ADHD drugs cost £44 million between April 2025 and June 2025 in EnglandPrescriptions for central nervous system (CNS) stimulants and drugs for Attention Deficit Hyperactivity ...
SHREVEPORT, La. - A cutting-edge clinical trial is now underway in Shreveport, and local patients with Multiple Sclerosis are ...
China NMPA accepts Bayer’s new drug application for gadoquatrane: Berlin Friday, September 19, 2025, 16:00 Hrs [IST] Bayer announced that the Center of Drug Evaluation of Chinas ...
Newspoint on MSN
Alcohol Affects the Nervous System: Why does one get high after drinking alcohol? How does the human nervous system work?
What effects does alcohol have on the nervous system and brain? Learn how it changes mood, thinking, and behavior. Alcohol ...
Scientists have turned an old idea on its head. A new paper reports that stretches of so-called “junk DNA” can help injured ...
Aside from carb-rich whole grains, other food sources of serotonin-boosting tryptophan include nuts and pulses like beans and ...
Complex Regional Pain Syndrome (CRPS), a neurological disorder affecting the central and peripheral nervous systems, ...
SKNY transaction strengthens MIRA pipeline with SKNY-1, a differentiated oral candidate that has demonstrated up to 30% ...
From dark chocolate to spaghetti, these serotonin foods can help lift your spirits and support both gut and brain health ...
Vertex faces pressure from potential U.S. drug pricing reforms and tariffs. Click here to find out why VRTX stock is a Hold.
The NDA for gadoquatrane has been filed for contrast-enhanced magnetic resonance imaging of the central nervous system (CNS) and other body regions in adults and pediatric patients including neonates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback